| 5.0M |
| $438.6M |
| +4.7% |
| 4.699% |
| 0.02% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | $362.8M | +2.3% | 3.887% | 0.01% |
| 5 | Parallel Advisors, LLC | 4.0M | $344.5M | -0.4% | 3.691% | 5.25% |
| 6 | FMR LLC | 3.3M | $290.2M | +4.6% | 3.109% | 0.01% |
| 7 | STATE STREET CORP | 3.3M | $285.2M | +2.5% | 3.055% | 0.00% |
| 8 | AQR CAPITAL MANAGEMENT LLC | 2.6M | $224.6M | +535.8% | 2.406% | 0.08% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.5M | $220.2M | -6.7% | 2.359% | 0.01% |
| 10 | FIRST TRUST ADVISORS LP | 1.8M | $159.1M | -15.8% | 1.704% | 0.09% |
| 11 | TANG CAPITAL MANAGEMENT LLC | 1.5M | $130.4M | 0.0% | 1.397% | 5.92% |
| 12 | UBS Group AG | 1.4M | $119.8M | +1.0% | 1.283% | 0.02% |
| 13 | DIMENSIONAL FUND ADVISORS LP | 1.3M | $114.7M | -15.1% | 1.229% | 0.02% |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | $100.7M | +3.4% | 1.078% | 0.01% |
| 15 | MORGAN STANLEY | 1.1M | $98.9M | +11.7% | 1.060% | 0.01% |
| 16 | D. E. Shaw & Co., Inc. | 883K | $76.8M | -25.3% | 0.823% | 0.04% |
| 17 | Cerity Partners LLC | 797K | $69.3M | +8.9% | 0.743% | 0.08% |
| 18 | MPM BioImpact LLC | 771K | $67.0M | -21.8% | 0.718% | 4.09% |
| 19 | NORTHERN TRUST CORP | 754K | $65.5M | +17.2% | 0.702% | 0.01% |
| 20 | EMERALD ADVISERS, LLC | 748K | $65.1M | +264.1% | 0.697% | 1.53% |
| 21 | FULLER & THALER ASSET MANAGEMENT, INC. | 710K | $61.7M | — | 0.661% | 0.17% |
| 22 | JACOBS LEVY EQUITY MANAGEMENT, INC | 696K | $60.5M | — | 0.648% | 0.22% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 614K | $53.4M | +4.0% | 0.572% | 0.01% |
| 24 | TWO SIGMA INVESTMENTS, LP | 610K | $53.0M | -35.5% | 0.568% | 0.04% |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 582K | $50.6M | -35.7% | 0.542% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in CORT — a direct measure of their conviction.
| 71.14% |
| 0.77 pp |
| $8.16B |
| +117% |
| Q4 2024 | 357 | +15% | 71.91% | 1.53 pp | $3.76B | +5.5% |
| Q3 2024 | 310 | — | 73.44% | — | $3.57B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
123 institutions opened new positions in CORT during Q2 2026, while 47 fully exited. 269 added to existing positions and 23 trimmed.
CORT institutional ownership rose by 1.89 percentage points quarter-over-quarter, with a net change of +80 holders.
The top 10 institutions account for 59.0% of all reported 13F value in CORT, and the top 25 account for 77.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Corcept Therapeutics Incorporated (CORT) Institutional Ownership